COVIVIO HOTELS SACA (COVH.PA) Fundamental Analysis & Valuation

EPA:COVH • FR0000060303

Current stock price

22.2 EUR
+0.1 (+0.45%)
Last:

This COVH.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. COVH.PA Profitability Analysis

1.1 Basic Checks

  • In the past year COVH was profitable.
  • COVH had a positive operating cash flow in the past year.
  • COVH had positive earnings in 4 of the past 5 years.
  • COVH had a positive operating cash flow in 4 of the past 5 years.
COVH.PA Yearly Net Income VS EBIT VS OCF VS FCFCOVH.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M

1.2 Ratios

  • COVH has a Return On Assets (2.89%) which is comparable to the rest of the industry.
  • With a Return On Equity value of 5.88%, COVH perfoms like the industry average, outperforming 55.81% of the companies in the same industry.
  • COVH's Return On Invested Capital of 3.68% is in line compared to the rest of the industry. COVH outperforms 58.14% of its industry peers.
Industry RankSector Rank
ROA 2.89%
ROE 5.88%
ROIC 3.68%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
COVH.PA Yearly ROA, ROE, ROICCOVH.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 -10

1.3 Margins

  • With an excellent Profit Margin value of 78.96%, COVH belongs to the best of the industry, outperforming 86.05% of the companies in the same industry.
  • COVH's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 101.55%, COVH belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • In the last couple of years the Operating Margin of COVH has grown nicely.
Industry RankSector Rank
OM 101.55%
PM (TTM) 78.96%
GM N/A
OM growth 3Y0.45%
OM growth 5Y15.26%
PM growth 3Y-12.76%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
COVH.PA Yearly Profit, Operating, Gross MarginsCOVH.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. COVH.PA Health Analysis

2.1 Basic Checks

  • COVH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • COVH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
COVH.PA Yearly Shares OutstandingCOVH.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
COVH.PA Yearly Total Debt VS Total AssetsCOVH.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • COVH has an Altman-Z score of 1.00. This is a bad value and indicates that COVH is not financially healthy and even has some risk of bankruptcy.
  • With a decent Altman-Z score value of 1.00, COVH is doing good in the industry, outperforming 65.12% of the companies in the same industry.
  • The Debt to FCF ratio of COVH is 12.71, which is on the high side as it means it would take COVH, 12.71 years of fcf income to pay off all of its debts.
  • COVH has a Debt to FCF ratio of 12.71. This is comparable to the rest of the industry: COVH outperforms 58.14% of its industry peers.
  • A Debt/Equity ratio of 0.70 indicates that COVH is somewhat dependend on debt financing.
  • COVH has a Debt to Equity ratio (0.70) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 12.71
Altman-Z 1
ROIC/WACC0.69
WACC5.33%
COVH.PA Yearly LT Debt VS Equity VS FCFCOVH.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 1.16 indicates that COVH should not have too much problems paying its short term obligations.
  • The Current ratio of COVH (1.16) is better than 81.40% of its industry peers.
  • COVH has a Quick Ratio of 1.16. This is a normal value and indicates that COVH is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of COVH (1.16) is better than 86.05% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
COVH.PA Yearly Current Assets VS Current LiabilitesCOVH.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. COVH.PA Growth Analysis

3.1 Past

  • COVH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.96%, which is quite impressive.
  • COVH shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -15.51% yearly.
  • The Revenue for COVH has decreased by -15.46% in the past year. This is quite bad
  • COVH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.97% yearly.
EPS 1Y (TTM)25.96%
EPS 3Y-15.51%
EPS 5YN/A
EPS Q2Q%86.66%
Revenue 1Y (TTM)-15.46%
Revenue growth 3Y-1.04%
Revenue growth 5Y8.97%
Sales Q2Q%-17.84%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-1.17%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.33%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
COVH.PA Yearly Revenue VS EstimatesCOVH.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
COVH.PA Yearly EPS VS EstimatesCOVH.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

4

4. COVH.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • COVH is valuated reasonably with a Price/Earnings ratio of 11.62.
  • Compared to the rest of the industry, the Price/Earnings ratio of COVH indicates a somewhat cheap valuation: COVH is cheaper than 67.44% of the companies listed in the same industry.
  • COVH's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.96.
  • A Price/Forward Earnings ratio of 12.88 indicates a correct valuation of COVH.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of COVH is on the same level as its industry peers.
  • When comparing the Price/Forward Earnings ratio of COVH to the average of the S&P500 Index (24.04), we can say COVH is valued slightly cheaper.
Industry RankSector Rank
PE 11.62
Fwd PE 12.88
COVH.PA Price Earnings VS Forward Price EarningsCOVH.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 67.44% of the companies in the same industry are more expensive than COVH, based on the Enterprise Value to EBITDA ratio.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as COVH.
Industry RankSector Rank
P/FCF 15.16
EV/EBITDA 16.52
COVH.PA Per share dataCOVH.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. COVH.PA Dividend Analysis

5.1 Amount

  • COVH has a Yearly Dividend Yield of 6.76%, which is a nice return.
  • COVH's Dividend Yield is a higher than the industry average which is at 5.46.
  • COVH's Dividend Yield is rather good when compared to the S&P500 average which is at 1.91.
Industry RankSector Rank
Dividend Yield 6.76%

5.2 History

  • The dividend of COVH decreases each year by -3.01%.
Dividend Growth(5Y)-3.01%
Div Incr Years4
Div Non Decr Years4
COVH.PA Yearly Dividends per shareCOVH.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • 19.15% of the earnings are spent on dividend by COVH. This is a low number and sustainable payout ratio.
  • The Dividend Rate of COVH has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP19.15%
EPS Next 2YN/A
EPS Next 3YN/A
COVH.PA Yearly Income VS Free CF VS DividendCOVH.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M
COVH.PA Dividend Payout.COVH.PA Dividend Payout, showing the Payout Ratio.COVH.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

COVH.PA Fundamentals: All Metrics, Ratios and Statistics

COVIVIO HOTELS SACA

EPA:COVH (3/16/2026, 7:00:00 PM)

22.2

+0.1 (+0.45%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-18
Earnings (Next)07-14
Inst Owners31.31%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap3.51B
Revenue(TTM)235.20M
Net Income(TTM)205.77M
Analysts82.86
Price Target18.67 (-15.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.76%
Yearly Dividend1.3
Dividend Growth(5Y)-3.01%
DP19.15%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 11.62
Fwd PE 12.88
P/S 13.46
P/FCF 15.16
P/OCF 9.59
P/B 1
P/tB 1.11
EV/EBITDA 16.52
EPS(TTM)1.91
EY8.6%
EPS(NY)1.72
Fwd EY7.76%
FCF(TTM)1.46
FCFY6.6%
OCF(TTM)2.32
OCFY10.43%
SpS1.65
BVpS22.14
TBVpS20.08
PEG (NY)N/A
PEG (5Y)N/A
Graham Number30.85
Profitability
Industry RankSector Rank
ROA 2.89%
ROE 5.88%
ROCE 4.15%
ROIC 3.68%
ROICexc 4.07%
ROICexgc 4.31%
OM 101.55%
PM (TTM) 78.96%
GM N/A
FCFM 88.79%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y0.45%
OM growth 5Y15.26%
PM growth 3Y-12.76%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 12.71
Debt/EBITDA 6.95
Cap/Depr 151.01%
Cap/Sales 51.57%
Interest Coverage 4.12
Cash Conversion 103.44%
Profit Quality 112.46%
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z 1
F-Score6
WACC5.33%
ROIC/WACC0.69
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.96%
EPS 3Y-15.51%
EPS 5YN/A
EPS Q2Q%86.66%
EPS Next Y-1.17%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.46%
Revenue growth 3Y-1.04%
Revenue growth 5Y8.97%
Sales Q2Q%-17.84%
Revenue Next Year2.33%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.53%
EBIT growth 3Y-0.59%
EBIT growth 5Y25.59%
EBIT Next Year-5.49%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-17.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.31%
OCF growth 3YN/A
OCF growth 5YN/A

COVIVIO HOTELS SACA / COVH.PA Fundamental Analysis FAQ

What is the fundamental rating for COVH stock?

ChartMill assigns a fundamental rating of 4 / 10 to COVH.PA.


What is the valuation status of COVIVIO HOTELS SACA (COVH.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to COVIVIO HOTELS SACA (COVH.PA). This can be considered as Fairly Valued.


How profitable is COVIVIO HOTELS SACA (COVH.PA) stock?

COVIVIO HOTELS SACA (COVH.PA) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for COVH stock?

The Price/Earnings (PE) ratio for COVIVIO HOTELS SACA (COVH.PA) is 11.62 and the Price/Book (PB) ratio is 1.


Can you provide the expected EPS growth for COVH stock?

The Earnings per Share (EPS) of COVIVIO HOTELS SACA (COVH.PA) is expected to decline by -1.17% in the next year.